Edition:
United States

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

1.68USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$1.68
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,035
52-wk High
$2.90
52-wk Low
$0.85

Chart for

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: -0.35
Market Cap(Mil.): $133.41
Shares Outstanding(Mil.): 79.41
Dividend: --
Yield (%): --

Financials

  CFRX.OQ Industry Sector
P/E (TTM): -- 103.50 32.14
EPS (TTM): -0.62 -- --
ROI: -169.13 1.52 12.66
ROE: -2,319.85 0.25 14.84

BRIEF-ContraFect Announces Q1 Loss Per Share $0.26

* CONTRAFECT - AS OF MARCH 31, 2018, HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $39.9 MILLION, COMPARED TO $46.9 MILLION AS OF DECEMBER 31, 2017

May 10 2018

Earnings vs. Estimates